Group One Trading
VIR icon

Group One Trading’s Vir Biotechnology VIR Stock Holding History

Group One Trading’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$138K Buy
15,400
+14,700
+2,100% +$117K ﹤0.01% 4431
2025
Q4 		$4.22K Hold
700
– – ﹤0.01% 7256
2025
Q3 		$4K Sell
700
-38,800
-98% -$198K ﹤0.01% 7652
2025
Q2 		$199K Buy
39,500
+27,600
+232% +$148K ﹤0.01% 4349
2025
Q1 		$77.1K Sell
11,900
-186,900
-94% -$1.66M ﹤0.01% 4812
2024
Q4 		$1.46M Buy
198,800
+198,700
+198,700% +$1.57M ﹤0.01% 2204
2024
Q3 		$749 Sell
100
-2,500
-96% -$21.7K ﹤0.01% 6335
2024
Q2 		$23.1K Sell
2,600
-3,800
-59% -$36.4K ﹤0.01% 5126
2024
Q1 		$64.8K Buy
6,400
+3,900
+156% +$39.7K ﹤0.01% 4496
2023
Q4 		$25.1K Sell
2,500
-88,900
-97% -$812K ﹤0.01% 5576
2023
Q3 		$856K Buy
91,400
+35,400
+63% +$505K ﹤0.01% 2419
2023
Q2 		$1.37M Buy
56,000
+55,700
+18,567% +$1.4M ﹤0.01% 2050
2023
Q1 		$6.98K Sell
300
-4,900
-94% -$125K ﹤0.01% 6135
2022
Q4 		$132K Buy
5,200
+2,800
+117% +$68.6K ﹤0.01% 4195
2022
Q3 		$46K Sell
2,400
-3,200
-57% -$81.3K ﹤0.01% 5481
2022
Q2 		$143K Sell
5,600
-4,200
-43% -$98.1K ﹤0.01% 4639
2022
Q1 		$252K Sell
9,800
-19,000
-66% -$564K ﹤0.01% 4557
2021
Q4 		$1.21M Sell
28,800
-2,000
-6% -$78.4K ﹤0.01% 3161
2021
Q3 		$1.34M Sell
30,800
-4,300
-12% -$186K ﹤0.01% 3087
2021
Q2 		$1.66M Sell
35,100
-29,700
-46% -$1.35M ﹤0.01% 2846
2021
Q1 		$3.32M Buy
64,800
+38,300
+145% +$2.06M ﹤0.01% 1928
2020
Q4 		$710K Buy
26,500
+13,600
+105% +$442K ﹤0.01% 2951
2020
Q3 		$443K Sell
12,900
-2,300
-15% -$99K ﹤0.01% 2950
2020
Q2 		$623K Buy
+15,200
New +$510K ﹤0.01% 2451

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Group One Trading's VIR Position: Q1 2026 in Review

Group One Trading sold out of Vir Biotechnology (VIR) in Q1 2026, closing a stake of 3,554 shares — an estimated $28.3K sold.

Group One Trading first reported a position in VIR in Q3 2020 and held it in 10 quarters. The position peaked at $1.32M in Q4 2024. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Group One Trading reported no remaining Vir Biotechnology position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 3,554 Vir Biotechnology shares in Q1 2026, an estimated $28.3K.
  • Group One Trading first reported a position in Vir Biotechnology in Q3 2020 and held it in 10 quarters.
  • Group One Trading's Vir Biotechnology position peaked at $1.32M in Q4 2024.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.